{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:38Z","timestamp":1788872438970,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":964,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2010 0002170"],"award-info":[{"award-number":["2010 0002170"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jjcc.2010.10.002","type":"journal-article","created":{"date-parts":[[2010,12,11]],"date-time":"2010-12-11T04:10:20Z","timestamp":1292040620000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["What is the optimal duration of triple anti-platelet therapy in patients with acute myocardial infarction undergoing drug-eluting stent implantation?"],"prefix":"10.1016","volume":"57","author":[{"given":"Keun-Ho","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Goo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jum Suk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Sun","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Sik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ju","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kye Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngkeun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Gwan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Chun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Chaee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2010.10.002_bib0005","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0010","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJMoa0801485","article-title":"Drug-eluting or bare-metal stents for acute myocardial infarction","volume":"359","author":"Mauri","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0015","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2009.03.013","article-title":"Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis","volume":"53","author":"Brar","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0020","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa0810116","article-title":"Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction","volume":"360","author":"Stone","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0025","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/jama.299.15.joc80026","article-title":"Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial","volume":"299","author":"Valgimigli","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1253\/circj.72.392","article-title":"Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry","volume":"72","author":"Lee","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0040","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.amjcard.2006.02.039","article-title":"Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up","volume":"98","author":"Park","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0045","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1161\/CIRCULATIONAHA.108.822791","article-title":"Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"119","author":"Chen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ahj.2009.01.006","article-title":"Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study","volume":"157","author":"Han","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4070\/kcj.2009.39.5.190","article-title":"Efficacy of triple anti-platelet therapy including cilostazol in acute myocardial infarction patients undergoing drug-eluting stent implantation","volume":"39","author":"Park","year":"2009","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","volume":"117","author":"King","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jacc.2007.11.049","volume":"51","author":"Lee","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in Myocardial Infarction (TIMI) Trial\u2014phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0075","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.105.594952","article-title":"Propensity scores in cardiovascular research","volume":"115","author":"D\u2019Agostino","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0080","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0085","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jacc.2008.09.058","article-title":"2-Year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry)","volume":"53","author":"Kaltoft","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0090","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0095","first-page":"964","article-title":"Long-term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial","volume":"120","author":"Di Lorenzo","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0100","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.107.762047","article-title":"Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study","volume":"118","author":"Nakazawa","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0105","first-page":"1144","article-title":"Effect of cilostazol on platelet aggregation and experimental thrombosis","volume":"35","author":"Kimura","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000138400","article-title":"Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle","volume":"36","author":"Tanaka","year":"1988","journal-title":"Pharmacology"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosissup.2005.09.002","article-title":"Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding","volume":"6","author":"Goto","year":"2005","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0120","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jacc.2005.07.048","article-title":"Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis","volume":"46","author":"Lee","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0125","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jacc.2008.12.025","volume":"53","author":"Jeong","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0130","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.100.1.21","article-title":"Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty","volume":"100","author":"Tsuchikane","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0140","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.104.530097","article-title":"Coronary stent restenosis in patients treated with cilostazol","volume":"112","author":"Douglas","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00005344-199212000-00009","article-title":"Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture","volume":"20","author":"Takahashi","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0150","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-2952(94)90062-0","article-title":"Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells","volume":"48","author":"Pan","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jjcc.2010.10.002_bib0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jcin.2008.02.006","article-title":"Should we routinely use drug-eluting stents for acute myocardial infarction? Let's wait and see","volume":"1","author":"Grines","year":"2008","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508710002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508710002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:48:23Z","timestamp":1760273303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508710002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0914508710002145"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2010.10.002","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the optimal duration of triple anti-platelet therapy in patients with acute myocardial infarction undergoing drug-eluting stent implantation?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2010.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}